There are two main types of lung cancer. Small-cell lung cancer (SCLC), sometimes called small-cell carcinoma, causes about 10%-15% of all lung cancer. Non-small-cell lung cancer (NSCLC ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with ...

Certain people with lung cancer are more likely to develop blood clots, including those with: non-small cell lung cancer (NSCLC) adenocarcinoma stage 3 or 4 lung cancer chemotherapy or surgery to ...

When Coretta received a diagnosis of stage 4 non-small cell lung cancer (NSCLC), she was shocked. Thanks to her oncologists, they established a care plan together. Having her treatment plan underway ...

"Most patients treated for small cell lung cancer experience rapid progression of disease and there is a high unmet need in the advanced setting," he added. "These interim results from the first ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer (SCLC) whose disease did not progress after concurrent platinum-based ...

This innovative vaccine, known as BNT116 and developed by BioNTech, is designed to combat non-small cell lung cancer ...